ANNUAL REPORT OF BEXIMCO PHARMA 2010 PDF

Beximco Pharmaceuticals Ltd. belongs to Beximco Group, the largest private This report titled “Financial Statement Analysis of Beximco Pharmaceuticals Ltd. in . Table Year. Beximco. Square. It is a broadly described annual report of Beximco Pharmaceuticals Limited in the year of During the year under review, overall sales of the company. It is a broadly described annual report of Beximco Pharmaceuticals Limited in the year of Sales revenue in the year crossed BDT billion with a.

Author: Sajind Nik
Country: Romania
Language: English (Spanish)
Genre: Art
Published (Last): 9 October 2014
Pages: 450
PDF File Size: 14.64 Mb
ePub File Size: 4.79 Mb
ISBN: 551-5-47725-482-5
Downloads: 7264
Price: Free* [*Free Regsitration Required]
Uploader: Gular

Strong institutional support is necessary for a vibrant capital market which is the core of economic development in any market based economic system.

Financial Statement Analysis of Beximco Pharmaceuticals Ltd – Assignment Point

The professional knowledge, thoughts and innovative ideas of the pharmacists working in this sector are the key factors for this developments. BPL is a well-established pharmaceutical company in Bangladesh. The major function of this section is to prepare financial report.

It was established in and converted into a public limited company in Highest selling drug in Bangladesh pharmaceutical market in terms of unit. In beximxo competition market, it is very hard to compete with one another. Financial statements are an aid in this respect because they serve the manager is appraising the performance of the subordinates. For the ratio analysis, Balance sheet and Income statement of Beximco pharmaceuticals is very important and data are availability from the Annual report e.

These supporting companies are as follows:. This internship is a part of the Bachelor of Business Administration BBA program that provides an on-the-job experience to students.

The report mainly analyzes the existing services of Beximco Pharmaceuticals Ltd. With the newly received product approvals from New Zealand, Kuwait and Azerbaijan, they plan to enter into these markets soon. Setting up electronic information services in regional centers for better and faster information exchange with the headquarters and the rest of the world.

Emerged as the most admired and highest selling nutritional supplement in Bangladesh Market in just one year. Authorized Capital in Taka: Their therapeutic groups host quality solutions for treating cardiovascular, musculoskeletal, Endocrine, gastrointestinal, metabolic, allergic, and respiratory other disorders.

  ERICSSON RBS 3206 PDF

The sections of Accounts and Finance department are as follows:. Beximco Pharma belongs to Beximco Group, the largest private sector industrial conglomerate in Bangladesh, with diversified activities into:.

The financial statements help them in judging such position. From the inception init has flourished into one of the top line conglomerates in Bangladesh today. Board of Directors is responsible for the corporate governance. They hope to persevere in stride in our service towards the progress of our country.

Ratios are calculated by comparing the current year figures to previous years, other companies, the industry, or even the economy to judge the performance of the company. Pacific Centre, rfport Floor, 14, Mohakhali C.

They prepare different types of cost reports.

Assignment Point – Solution for Best Assignment Paper

BPL believes new competitive advantages need to be identified to succeed in the industry and at present new comer activity becomes the most challenging job. Most of the top pharmaceutical companies are gearing up for the export market as most of them have been establishing GMP Good Manufacturing Practice compliance plants. Material cost and Operating Expense Budget and Monitoring. The financial statements prepared from time to time satisfy their curiosity. There has been a series of positive development in the year and their team successfully introduced 40 new generic formulations in 55 different presentations and expanded their dosage delivery portfolio with technology driven products like prefilled syrings, total parenteral nutrition, dry powder inhales etc.

Beximco Pharma will be one of the most trusted, admired and successful pharmaceuticals companies in the region with a focus on strengthening research and development capabilities, creating partnerships and building presence across the global.

This section of accounts and finance department does the reporting to the management. The Company introduced its own branded generic products in The Company continuously upgrades these systems in line with the best practices in the industry.

Annual Report of Beximco Pharmaceuticals Limited – Assignment Point

Today, Bangladesh Pharmaceutical Industry is successfully exporting APIs and a wide range of products covering all major therapeutic classes and dosage forms to 71 countries. Providing more specialized services to doctors of various disciplines. The submission of this report assures the University that the student has acquired two months of practical knowledge about real business world.

  DUAL XHD7714 MANUAL PDF

The information given in the financial statements is very useful to aannual number of parties as given below:. For a business enterprise, all the relevant financial information, presented in a structured manner and in a form easy to understand, are called the financial statements. Annual Report of BPL, But its journey to the growth and prosperity has been no bed of roses. Beximco Pharma offer their customers a comprehensive and high-quality product portfolio encompassing all major therapeutic categories, available in various dosage forms including tablets, capsules, syrup, suspension, sterile, eye drops, injectables, nasal sprays, creams, ointments, suppositories, IV fluids, metered dose inhales, dry powder, inhales, prefilled syrings etc.

The report compares the financial statement between Squire Pharmaceutical and Beximco Pharmaceutical for the year ended to Today Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets.

From annua, above chart Graph-1 we can see that current ratio in of Beximco is 2. Ideally, CSR policy repotr function as a built-in, self-regulating mechanism annkal business would monitor and ensure its adherence to law, annuap standards, and international norms.

Growth at par with the entire market meant that there cumulative holding did not change from level. Beximco has to be aware of those issues to become a market leader in the industry. AzmasolHighest selling mastered dose inhaler in Bangladesh in terms of value.

Manufacturing and marketing of Pharmaceutical Finished Formulation Products: So inexperience is one of the main constraints of the repoort.